ASK10 MMP/TIMP Family Antibody Sampler Kit I

ASK10
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service
      View Pricing & Availability

      Overview

      Replacement Information

      Key Specifications Table

      Pricing & Availability

      Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
      ASK10-1EA
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service
          Contact Customer Service

          Plastic ampoule 1 ea
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewContains 20 µg of each antibody. Includes Anti-MMP-1 (Cat. No. IM35), Anti-MMP-2 (Cat. No. IM33), Anti-MMP-3 (Cat. No. IM36), Anti-MMP-9 (Cat. Nos. IM09 and IM37), Anti-TIMP-1 (Cat. No. IM32), and Anti-TIMP-2 (Cat. No. IM11). Please see individual product descriptions for more information.
          Catalogue NumberASK10
          Brand Family Calbiochem®
          Application Data


          References
          ReferencesHöyhtyä, M., et al. 1994. Int. J. Cancer. 56, 500.
          Cottam, D. W. and Rees, R. C. 1993. Intl J. Oncol. 2, 861.
          Fujimoto, N., et al. 1993. Clinica Chimica Acta. 221, 91.
          Nakajima, M., et al. 1993. Cancer Res. 53, 5802.
          Stetler-Stevenson, W. G., et al. 1993. FASEB J. 7, 1434.
          Zhang, J., et al. 1993. Clinica Chimica Acta. 219, 1.
          Zucker, S., et al. 1993. Cancer Res. 53, 140.
          Obata, K., et al. 1992. Clinica Chimica Acta. 211, 59.
          Woessner, J. F. 1991. FASEB J. 5, 2145.
          Liotta, L. A. and Stetler-Stevenson, W. G. 1990. in Seminars in Cancer Biology, ed. M. M. Gottesman. Vol.1(2); 99-102.
          Kodama, S., et al. 1987. Collagen Rel. Res. 7, 341.
          Product Information
          DeclarationManufactured by Daiichi Fine Chemical Co., Ltd. Not available for sale in Japan.
          FormLiquid
          Formulation20 µg of each antibody in 100 mM sodium phosphate buffer, 0.1% BSA, pH 7.4.
          Preservative≤0.1% sodium azide
          Applications
          Application ReferencesMMP-9 (Ab-2) Frozen and Paraffin Sections Aikawa, M, et al. 1998. Circ. Res. 83, 1015. MMP-2 (Ab-3) Paraffin Sections: Tsuchiya, Y., et al. 1994. Int. J. Cancer. 56, 46. MMP-1 (Ab-1), MMP-2 (Ab-3), and MMP-3 (Ab-1) Frozen Sections Nakagawa, T., et al. 1994. J. Neurosurg. 81, 69. MMP-1 (Ab-1) Paraffin Sections: Zhang, J., et al. 1993. Clinica Chimica Acta. 219, 1. MMP-2 (Ab-3) Paraffin Sections Nomura H., et al. 1996. Int. J. Cancer 69, 9. Obata, K., et al. 1992. Clinica Chimica Acta. 211, 59. (called clone B) MMP-9 (Ab-1) Enzyme Inhibition: Ramos-DeSimone, N., et al. 1993. Hybridoma 12, 349. MMP-9 (Ab-1) and MMP-9 (Ab-2) Immunoprecipitation Ramos-DeSimone, N. and French, D. L. 1994. Ann. NY Acad. Sci. 732, 469. TIMP-1 (Ab-1) Imunohistochemistry Okada, Y., et al. 1990. Virchows Arch. B Cell Pathol. 59, 305. TIMP-2 (Ab-1) Immunoprecipitation and Frozen Sections Höyhtyä, M., et al. 1994. Int. J. Cancer. 56, 500.
          Application NotesFrozen Sections (see characteristics below)
          Immunoblotting (see characteristics below)
          Immunoprecipitation (see characteristics below)
          Paraffin Sections (see characteristics below)
          Application CommentsFor an MMP-1 or MMP-3 positive control, incubate HT-1080 cells for 2 hours at 37°C in serum-free media containing 100 nM PMA. Collect and centrifuge medium; concentrate as necessary. Store in aliquots at -20°C. When staining paraffin sections for MMP-1, pretreatment with heat, saponin, or trypsin can be used, but a pressure cooker generally gives the best results. Anti-MMP-9 (Ab-1) recognizes both the latent and active forms of MMP-9 under non-reducing conditions but only the latent form under reducing conditions. Anti-MMP-9 (Ab-1) will inhibit MMP-9 enzymatic activity. Anti-MMP-9 (Ab-2) recognizes only the latent form of MMP-9 (non-reducing or reducing conditions). Anti-TIMP-1 (Ab-1) will react with TIMP-1 and MMP/TIMP-1 complexes. Antibodies should be titrated for optimal results in individual systems.
          Biological Information
          Concentration Label Please refer to vial label for lot-specific concentration
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Blue Ice Only
          Toxicity Standard Handling
          Storage -20°C
          Avoid freeze/thaw Avoid freeze/thaw
          Do not freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          MMP/TIMP Family Antibody Sampler Kit I SDS

          Title

          Safety Data Sheet (SDS) 

          MMP/TIMP Family Antibody Sampler Kit I Certificates of Analysis

          TitleLot Number
          ASK10

          References

          Reference overview
          Höyhtyä, M., et al. 1994. Int. J. Cancer. 56, 500.
          Cottam, D. W. and Rees, R. C. 1993. Intl J. Oncol. 2, 861.
          Fujimoto, N., et al. 1993. Clinica Chimica Acta. 221, 91.
          Nakajima, M., et al. 1993. Cancer Res. 53, 5802.
          Stetler-Stevenson, W. G., et al. 1993. FASEB J. 7, 1434.
          Zhang, J., et al. 1993. Clinica Chimica Acta. 219, 1.
          Zucker, S., et al. 1993. Cancer Res. 53, 140.
          Obata, K., et al. 1992. Clinica Chimica Acta. 211, 59.
          Woessner, J. F. 1991. FASEB J. 5, 2145.
          Liotta, L. A. and Stetler-Stevenson, W. G. 1990. in Seminars in Cancer Biology, ed. M. M. Gottesman. Vol.1(2); 99-102.
          Kodama, S., et al. 1987. Collagen Rel. Res. 7, 341.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision03-December-2007 JSW
          ApplicationFrozen Sections (see characteristics below)
          Immunoblotting (see characteristics below)
          Immunoprecipitation (see characteristics below)
          Paraffin Sections (see characteristics below)
          Application Data


          DescriptionContains 20 µg of each antibody. Includes Anti-MMP-1 (Cat. No. IM35), Anti-MMP-2 (Cat. No. IM33), Anti-MMP-3 (Cat. No. IM36), Anti-MMP-9 (Cat. Nos. IM09 and IM37), Anti-TIMP-1 (Cat. No. IM32), and Anti-TIMP-2 (Cat. No. IM11). Please see individual product descriptions for more information. The antibodies to MMP-1, MMP-2, and MMP-3 recognize both latent and active forms.
          BackgroundMatrix metalloproteinases (MMPs) are a family of enzymes that are responsible for the degradation of extracellular matrix components such as collagen, laminin and proteoglycans. All MMPs share: sequence homology, a catalytic mechanism dependent upon a zinc ion at the active center, ability to cleave one or more extracellular matrix components, secretion as zymogens which are activated by removal of an approximately 10 kDa segment from the N-terminus, and regulation by endogenous inhibitors. These enzymes are involved in normal physiological processes as well as in metastasis. MMP-2 and MMP-9 are members of the gelatinase family and elevated levels may be correlated with metastatic potential. MMP-1 is also known as interstitial collagenase and MMP-3 as stromelysin-1. Activation and activity of the MMP's are regulated by the TIMP (tissue inhibitors of metalloproteinase) family members. TIMP-1 preferentially regulates MMP-9 and TIMP-2 regulates MMP-2.
          FormLiquid
          Formulation20 µg of each antibody in 100 mM sodium phosphate buffer, 0.1% BSA, pH 7.4.
          Concentration Label Please refer to vial label for lot-specific concentration
          Preservative≤0.1% sodium azide
          CommentsFor an MMP-1 or MMP-3 positive control, incubate HT-1080 cells for 2 hours at 37°C in serum-free media containing 100 nM PMA. Collect and centrifuge medium; concentrate as necessary. Store in aliquots at -20°C. When staining paraffin sections for MMP-1, pretreatment with heat, saponin, or trypsin can be used, but a pressure cooker generally gives the best results. Anti-MMP-9 (Ab-1) recognizes both the latent and active forms of MMP-9 under non-reducing conditions but only the latent form under reducing conditions. Anti-MMP-9 (Ab-1) will inhibit MMP-9 enzymatic activity. Anti-MMP-9 (Ab-2) recognizes only the latent form of MMP-9 (non-reducing or reducing conditions). Anti-TIMP-1 (Ab-1) will react with TIMP-1 and MMP/TIMP-1 complexes. Antibodies should be titrated for optimal results in individual systems.
          Storage -20°C
          Avoid freeze/thaw
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
          Toxicity Standard Handling
          ReferencesHöyhtyä, M., et al. 1994. Int. J. Cancer. 56, 500.
          Cottam, D. W. and Rees, R. C. 1993. Intl J. Oncol. 2, 861.
          Fujimoto, N., et al. 1993. Clinica Chimica Acta. 221, 91.
          Nakajima, M., et al. 1993. Cancer Res. 53, 5802.
          Stetler-Stevenson, W. G., et al. 1993. FASEB J. 7, 1434.
          Zhang, J., et al. 1993. Clinica Chimica Acta. 219, 1.
          Zucker, S., et al. 1993. Cancer Res. 53, 140.
          Obata, K., et al. 1992. Clinica Chimica Acta. 211, 59.
          Woessner, J. F. 1991. FASEB J. 5, 2145.
          Liotta, L. A. and Stetler-Stevenson, W. G. 1990. in Seminars in Cancer Biology, ed. M. M. Gottesman. Vol.1(2); 99-102.
          Kodama, S., et al. 1987. Collagen Rel. Res. 7, 341.
          Application referencesMMP-9 (Ab-2) Frozen and Paraffin Sections Aikawa, M, et al. 1998. Circ. Res. 83, 1015. MMP-2 (Ab-3) Paraffin Sections: Tsuchiya, Y., et al. 1994. Int. J. Cancer. 56, 46. MMP-1 (Ab-1), MMP-2 (Ab-3), and MMP-3 (Ab-1) Frozen Sections Nakagawa, T., et al. 1994. J. Neurosurg. 81, 69. MMP-1 (Ab-1) Paraffin Sections: Zhang, J., et al. 1993. Clinica Chimica Acta. 219, 1. MMP-2 (Ab-3) Paraffin Sections Nomura H., et al. 1996. Int. J. Cancer 69, 9. Obata, K., et al. 1992. Clinica Chimica Acta. 211, 59. (called clone B) MMP-9 (Ab-1) Enzyme Inhibition: Ramos-DeSimone, N., et al. 1993. Hybridoma 12, 349. MMP-9 (Ab-1) and MMP-9 (Ab-2) Immunoprecipitation Ramos-DeSimone, N. and French, D. L. 1994. Ann. NY Acad. Sci. 732, 469. TIMP-1 (Ab-1) Imunohistochemistry Okada, Y., et al. 1990. Virchows Arch. B Cell Pathol. 59, 305. TIMP-2 (Ab-1) Immunoprecipitation and Frozen Sections Höyhtyä, M., et al. 1994. Int. J. Cancer. 56, 500.